Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlook

Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlook

January 30, 2025

10

Takeda Pharmaceutical Non-GAAP EPS of ¥443.00, revenue of ¥3528.2B; raises FY outlook — jetcityimage/iStock Editorial via Getty Images

Takeda Pharmaceutical (NYSE:TAK) has upgraded its full year outlook for growth, reflecting strong year-to-date product performance and reports results for the nine months ended December 31, 2024.
Non-GAAP EPS of ¥443.00 for the nine months ended December 31, 2024.
Revenue of ¥3528.2B (+9.8% Y/Y).
Core Operating Profit

Previous article

NIGHT TIME SKIN CARE ROUTINE 🤭

Next article

European embedded banking startup Swan adds another $44 million to its Series B

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

LATEST POSTS

Most Popular